Asthma Meds Don’t Work as Well in Overweight Patients
The inhaled steroids that are often used to treat asthma don't work as well in the overweight or obese, new research shows.
APT Pharmaceuticals Secures $32 Million in Series B Financing
APT Pharmaceuticals, a specialty drug development company focused on inhaled treatments for serious lung diseases, announced today the completion of a $32.3 million Series B financing.
District Court Affirms Patent Infringement Rulings and Finds That Amgen is Entitled to a Permanent Injunction against Roche
Court Also Upholds Validity of Patent Claim in TKT and Aventis Litigation THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ:AMGN) announced today that the United States (U.S.) District Court in Boston issued its written decision upholding the...Cardinal Health Inc., Agrees to Pay $34 Million to Settle Claims That it Failed to Report Suspicious Sales of Widely-Abused Controlled Substances
WASHINGTON, Oct. 2 /PRNewswire-USNewswire/ -- Cardinal Health Inc., one of the nation's largest distributors of pharmaceutical drugs, has agreed to settle allegations that it violated federal reporting provisions relating to its handling of certain...Severe Adverse Event Reported in Raptiva Patient
GENEVA, Switzerland, October 2/PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that Genentech Inc. has reported a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had...Cardinal Health Resolves Controlled Substance License Suspensions
Company expects to resume shipments of controlled substances from its Auburn, Wash., Lakeland, Fla. and Swedesboro, N.J. distribution facilities by end of November DUBLIN, Ohio, Oct. 2 /PRNewswire-FirstCall/ -- Cardinal Health, a global...Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
SOUTH SAN FRANCISCO, Calif. -- October 2, 2008 -- Genentech, Inc. (NYSE: DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal...Insecticides still best treatment for head lice, pediatricians advise
Lice do not cause disease, but because they are easily transferred from head to head they can create headaches for parents and children.
Nebion HLX-8 Magnetic Resonance Device
Device recalled because it was not approved by FDA, lacked safety and effectiveness data, and was not manufactured under current good manufacturing practices.New Class of Drugs Might Cause Congenital Heart Defects
An animal study raises a warning sign that a new class of drugs that shows promise against a variety of ailments ranging from cancer to Alzheimer's disease might cause congenital heart defects, researchers ...
« go back — keep looking »